Mass Spectrometry –Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma

We report a sensitive and robust targeted mass spectrometry proteomics method to detect MRD in serum, without the need of invasive, sequential bone marrow aspirates.

Source: Journal of Molecular Diagnostics - April 13, 2020 Category: Pathology Authors: Carlo O. Martins, Sarah Huet, San S. Yi, Maria S. Ritorto, Ola Landgren, Ahmet Dogan, Jessica R. Chapman Source Type: research